Association of continuous glucose monitoring-derived time in range with major amputation risk in diabetic foot osteomyelitis patients undergoing amputation

被引:6
作者
Yin, Xueyao [1 ]
Zhu, WeiFen [1 ]
Liu, Chao [2 ]
Yao, Huilan [3 ]
You, Jiaxing [2 ]
Chen, Yixin [1 ]
Ying, Xiaofang [4 ]
Li, Lin [1 ]
机构
[1] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Endocrinol, 3 East Qingchun Rd, Hangzhou 310016, Peoples R China
[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Orthoped, Hangzhou, Peoples R China
[3] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Nursing Educ, Sch Med, Hangzhou, Peoples R China
[4] Jiangshan Peoples Hosp, Dept Endocrinol, Quzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
continuous glucose monitoring; diabetic foot osteomyelitis; major amputation; time in range; CLINICAL-USE; INFECTION; DISEASE; COMPLICATIONS; HYPOGLYCEMIA; HEMOGLOBIN; MORTALITY; ISCHEMIA; EUROPE; ADULTS;
D O I
10.1177/20420188221099337
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The metrics generated from continuous glucose monitoring (CGM), such as time in range (TIR), are strongly correlated with diabetes complications. This study explored the association of perioperative CGM-derived metrics with major amputation risk in patients with diabetic foot osteomyelitis (DFO). Methods: This study recruited 55 DFO patients with grade 3-4 wounds according to the Wagner Diabetic Foot Ulcer Classification System, all of whom underwent CGM for 5 days during the perioperative period. The CGM-derived metrics were defined in accordance with the most recent international consensus recommendations. Results: Patients with major amputation had significantly less TIR and higher time below range (TBR) (all p < 0.05). In binary logistic regression analyses, a lower TIR was associated with the risk of major amputation (odds ratio: 0.83 (95% confidence interval: 0.71-0.99), p = 0.039). This association remained statistically significant after adjustments for age, sex, body mass index, type of diabetes, smoking, drinking, durations of diabetes and DFU, ankle-brachial index, albumin, estimated-glomerular filtration rate, Society for Vascular Surgery wound, ischemia, and foot infection (WIfi) stage, multidrug-resistant organisms, and hemoglobin A1c. Further adjustment for the mean amplitude of glycemic excursion (MAGE) reduced this association. TBR was also independently associated with the risk of major amputation (odds ratio: 1.60 (95% confidence interval: 1.17-2.18), p = 0.003); this association persisted after adjustment for MAGE. Conclusion: Perioperative TIR (3.9-10.0 mmol/L) and TBR (<3.9 mmol/L) were significantly associated with major amputation in hospitalized patients with DFO.
引用
收藏
页数:9
相关论文
共 37 条
  • [1] Impact of perioperative glycaemia and glycated haemoglobin on the outcomes of the surgical treatment of diabetic foot osteomyelitis
    Aragon-Sanchez, Javier
    Luis Lazaro-Martinez, Jose
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (03) : E83 - E85
  • [2] Diabetic Foot Ulcers and Their Recurrence
    Armstrong, David G.
    Boulton, Andrew J. M.
    Bus, Sicco A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (24) : 2367 - 2375
  • [3] Hypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes
    Balijepalli, Chakrapani
    Druyts, Eric
    Siliman, Gaye
    Joffres, Michel
    Thorlund, Kristian
    Mills, Edward J.
    [J]. CLINICAL EPIDEMIOLOGY, 2017, 9 : 291 - 296
  • [4] Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
    Battelino, Tadej
    Danne, Thomas
    Bergenstal, Richard M.
    Amiel, Stephanie A.
    Beck, Roy
    Biester, Torben
    Bosi, Emanuele
    Buckingham, Bruce A.
    Cefalu, William T.
    Close, Kelly L.
    Cobelli, Claudio
    Dassau, Eyal
    DeVries, J. Hans
    Donaghue, Kim C.
    Dovc, Klemen
    Doyle, Francis J.
    Garg, Satish
    Grunberger, George
    Heller, Simon
    Heinemann, Lutz
    Hirsch, Irl B.
    Hovorka, Roman
    Jia, Weiping
    Kordonouri, Olga
    Kovatchev, Boris
    Kowalski, Aaron
    Laffel, Lori
    Levine, Brian
    Mayorov, Alexander
    Mathieu, Chantal
    Murphy, Helen R.
    Nimri, Revital
    Norgaard, Kirsten
    Parkin, Christopher G.
    Renard, Eric
    Rodbard, David
    Saboo, Banshi
    Schatz, Desmond
    Stoner, Keaton
    Urakami, Tatsuiko
    Weinzimer, Stuart A.
    Phillip, Moshe
    [J]. DIABETES CARE, 2019, 42 (08) : 1593 - 1603
  • [5] The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading
    Beck, Roy W.
    Connor, Crystal G.
    Mullen, Deborah M.
    Wesley, David M.
    Bergenstal, Richard M.
    [J]. DIABETES CARE, 2017, 40 (08) : 994 - 999
  • [6] Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome
    Benfield, T.
    Jensen, J. S.
    Nordestgaard, B. G.
    [J]. DIABETOLOGIA, 2007, 50 (03) : 549 - 554
  • [7] Predictors of Severity in Diabetic Foot Infections
    Callahan, Devon
    Keeley, Jessica
    Alipour, Hamid
    DeVirgilio, Christian
    Kaji, Amy
    Plurad, David
    Kim, Dennis Y.
    [J]. ANNALS OF VASCULAR SURGERY, 2016, 33 : 103 - 108
  • [8] Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes
    Carlson, Anders L.
    Mullen, Deborah M.
    Bergenstal, Richard M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 : S4 - S11
  • [9] Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes
    Guo, Qingyu
    Zang, Pu
    Xu, Shaoying
    Song, Wenjing
    Zhang, Zhen
    Liu, Chunyan
    Guo, Zhanhong
    Chen, Jing
    Lu, Bin
    Gu, Ping
    Shao, Jiaqing
    [J]. JOURNAL OF DIABETES RESEARCH, 2020, 2020
  • [10] Should minimal blood glucose variability become the gold standard of glycemic control?
    Hirsch, IB
    Brownlee, M
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2005, 19 (03) : 178 - 181